Clinical Trial: Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers Syndrome

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional




Official Title: Pilot Study of mTOR Inhibitor Therapy for Treatment of Intestinal Polyps in Peutz-Jeghers Syndrome

Brief Summary:

Pilot study, Open-label, Phase II study of Everolimus.

Objective:

To determine if Everolimus can diminish large gastrointestinal polyps in patients with Peutz-Jeghers Syndrome.

Methodology:

Polyp size and number will be compared to baseline by FDG-PET and CT and 12 months after treatment with Everolimus. Since this is a pilot study, the polyps prior to treatment will serve as the controls.